chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Drug intolerance, Electrocardiogram abnormal, Electrocardiogram ambulatory abnormal, Extrasystoles, Food intolerance
Clinical narrative: I woke up with a heart rate over 190 bpm. Started getting painful, sharp PVC's (diagnosed in 2022). My PVC's were around 20-40 a day at first then grew to 5k to 10k per day, so every 5 to 10 beats would skip. My blood pressure at times was 190/125. I would rush to the ER for them to say nothing was wrong except my bp was up. I had no clue there was vaccine injury compensation available or else I would have applied. I had edema in my right leg (diagnosed 7/21). Migraines for the first time in my life lasting for weeks. Sudden chest pains that almost knocked me to the ground. Would go get blood checked and I had no signs of heart attack. Shooting pains through my right temple. The PVC's come and go. I'll go weeks without one sometimes but when they're bad I want to commit suicide sometimes just to be done with the torture.  I can't drink coffee or any alcohol. Eat steak, bacon, cheese, too much milk, etc. Any fattening foods make the PVC's worse. Caffeine, chocolate, and sleeping medicine all make the PVC's much worse.  I am doing a tremendous amount of self care, dieting, and exercise plus supplements to keep the PVC's in check but I'll get bad bouts of it where I'll get 10k+ PVC's a day
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Migraine, Oedema peripheral, Pain, Scan myocardial perfusion abnormal
Clinical narrative: I woke up with a heart rate over 190 bpm. Started getting painful, sharp PVC's (diagnosed in 2022). My PVC's were around 20-40 a day at first then grew to 5k to 10k per day, so every 5 to 10 beats would skip. My blood pressure at times was 190/125. I would rush to the ER for them to say nothing was wrong except my bp was up. I had no clue there was vaccine injury compensation available or else I would have applied. I had edema in my right leg (diagnosed 7/21). Migraines for the first time in my life lasting for weeks. Sudden chest pains that almost knocked me to the ground. Would go get blood checked and I had no signs of heart attack. Shooting pains through my right temple. The PVC's come and go. I'll go weeks without one sometimes but when they're bad I want to commit suicide sometimes just to be done with the torture.  I can't drink coffee or any alcohol. Eat steak, bacon, cheese, too much milk, etc. Any fattening foods make the PVC's worse. Caffeine, chocolate, and sleeping medicine all make the PVC's much worse.  I am doing a tremendous amount of self care, dieting, and exercise plus supplements to keep the PVC's in check but I'll get bad bouts of it where I'll get 10k+ PVC's a day
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Suicidal ideation, Ventricular extrasystoles
Clinical narrative: I woke up with a heart rate over 190 bpm. Started getting painful, sharp PVC's (diagnosed in 2022). My PVC's were around 20-40 a day at first then grew to 5k to 10k per day, so every 5 to 10 beats would skip. My blood pressure at times was 190/125. I would rush to the ER for them to say nothing was wrong except my bp was up. I had no clue there was vaccine injury compensation available or else I would have applied. I had edema in my right leg (diagnosed 7/21). Migraines for the first time in my life lasting for weeks. Sudden chest pains that almost knocked me to the ground. Would go get blood checked and I had no signs of heart attack. Shooting pains through my right temple. The PVC's come and go. I'll go weeks without one sometimes but when they're bad I want to commit suicide sometimes just to be done with the torture.  I can't drink coffee or any alcohol. Eat steak, bacon, cheese, too much milk, etc. Any fattening foods make the PVC's worse. Caffeine, chocolate, and sleeping medicine all make the PVC's much worse.  I am doing a tremendous amount of self care, dieting, and exercise plus supplements to keep the PVC's in check but I'll get bad bouts of it where I'll get 10k+ PVC's a day
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Fatigue, SARS-CoV-2 test positive
Clinical narrative: Around 8/7/22 I had slightly elevated temperature of around 99.5; overall weakness and fatigue; slight cough;  Covid home test was positive; event lasted 2-3  days; Dr prescribed Molnupiravir course over 5 days; felt better after 3-4 days
Age: 52.0
Sex: M
Vaccine: HEP, VARZOS
Symptoms: Chills, Fatigue, Headache, Hypersomnia, Pain
Clinical narrative: Pt developed fatigue evening of vaccine admin. Pt woke up following AM around 5/5:30AM for work and with "horrible HA", chills, body aches. Denies associated cough/congestion, rhinorrhea. HA is unamendable to Tylenol. He is fatigued and has slept most of the day. Advised to treat with ibuprofen, hydration, rest.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three vaccines Moderna 3/5/21 LOt# 004M20A;  Moderna 3/9/21 Lot# 012L20A;  Moderna 11/17/21 Lot# 065F  DO NOT REQUEST THE LOT NUMBER;  THIS IS ALL THE INFORMATION IN THE LOCAL DATABASE
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: na
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dizziness, Dyspnoea, Hypoxia
Clinical narrative: Hospitalization 8/15/22-8/18/22 weakness, cough, SOB, lightheadedness, fever, pleural effusion, hypoxia, UTI, thrombocytopenia,
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pleural effusion, Pyrexia, Thrombocytopenia, Urinary tract infection
Clinical narrative: Hospitalization 8/15/22-8/18/22 weakness, cough, SOB, lightheadedness, fever, pleural effusion, hypoxia, UTI, thrombocytopenia,
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Urticaria
Clinical narrative: Generalized hives developed 72 hrs. after vaccination. Intense itching, large areas of red rash over entire body. Hives have not resolved and are present every day.
Age: 7.0
Sex: F
Vaccine: FLU4
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: Reported by a member of the public that child received flu vaccine at school-based clinic without parental signature on form. Nurse reviewed all documents from clinic and found one form that had been filled out, send into the school, but not signed by a parent/guardian.  Call to mother of child by Public Health Director x2; voicemail left for her to call us back.
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest pain, Electrocardiogram, Gastrooesophageal reflux disease, Heart rate increased
Clinical narrative: fast and slow heart beats  chest pains acid reflux
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular
Clinical narrative: fast and slow heart beats  chest pains acid reflux
Age: 30.0
Sex: F
Vaccine: UNK
Symptoms: Urticaria
Clinical narrative: 12 days after receipt of the vaccine I developed urticaria (chronic hives.) To date since the receipt of the vaccine I still have chronic hives. There were no other changes to my normal routine during this time.  In early 2022 I went to an allergist MD who treated me for my hives and I now take daily allergy medication to alleviate the hives (which I never needed prior to the third dose of the Moderna vaccine.)
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Total hair loss- alopecia
Age: 21.0
Sex: M
Vaccine: TDAP
Symptoms: Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: chills, nausea, muscle aches, fever overnight. Treated with rest and tylenol
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient had symptom onset on 11/6/2022 with cough and body aches. He tested positive for COVID-19 on 11/6/2022 at store with a NAA test. He had a known exposure to a positive COVID-19 case. Patient?s oncologist ordered outpatient monoclonal antibody infusion to treat the COVID. After IV insertion on 11/7/2022 in the outpatient department, patient had syncope and collapse and therefore he never received the monoclonal antibody infusion. He was admitted directly to the hospital for principal problem of syncope and collapse. and secondarily for COVID-19. Chest x-ray on 11/7/2022 showed findings suggestive of the beginnings of COVID-pneumonia with subtle ground glass opacity in the lateral mid and lower right lung. Vital signs normal but patient was initially hypoxic and put on oxygen. He improved and was no longer hypoxic, so oxygen removed. Patient denied shortness of breath or chest pain. He developed nausea, vomiting, diarrhea overnight on admission which was likely due to COVID. Patient continued to receive hospital care from 11/8/2022-11/10/2022 including IV fluids, vitamin C and zinc; no steroids needed. Monoclonal antibody treatment was considered as outpatient after discharge on 11/10/2022, as patient was eligible through 11/11/2022. Unknown if patient received MAB treatment.  On 11/22/2022, the patient presented at the emergency room with persistent cough and fevers. He was tested for COVID-19 and had positive COVID-19 antigen and PCR test results on 11/22/2022. He initially had tested positive on 11/6/2022. Patient complained of weakness, congestion, diarrhea, had a coarse deep sounding cough, and was dehydrated ? IV fluids given. Chest x-ray on 11/22/2022 showed no evidence of pneumonia; significantly low lung volumes; No definite focal airspace disease; mild central vascular congestion. Patient was admitted to the hospital on 11/22/2022 with principal problem of COVID-19 Virus Infection and secondary problem of Urinary Tract Infection associated with indwelling catheter. Further treatment and discharge information unknown.   On 11/30/2022, patient presented to the emergency room with 24-hour history of shortness of breath, cough, fever, fatigue and diarrhea. He had respiratory distress and hypoxia requiring oxygen. He was tested on 12/1/2022 for COVID-19 and had a positive NAA test. He initially tested COVID-19 positive on 11/6/2022, tested positive again on 11/22/2022, and on 12/1/2022. Patient was admitted to the hospital on 11/30/2022. Treatment included oxygen, steroids, nebulizers, broad spectrum antibiotics, and spot doses of diuretic. His condition worsened and on 12/4/2022 he requested to be transitioned to comfort measures. Patient expired on 12/5/2022. Death abstract states:  Acute Respiratory Failure, Pneumonia, and COVID-19 as causes of death.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Dehydration, Device related infection, Diarrhoea
Clinical narrative: Patient had symptom onset on 11/6/2022 with cough and body aches. He tested positive for COVID-19 on 11/6/2022 at store with a NAA test. He had a known exposure to a positive COVID-19 case. Patient?s oncologist ordered outpatient monoclonal antibody infusion to treat the COVID. After IV insertion on 11/7/2022 in the outpatient department, patient had syncope and collapse and therefore he never received the monoclonal antibody infusion. He was admitted directly to the hospital for principal problem of syncope and collapse. and secondarily for COVID-19. Chest x-ray on 11/7/2022 showed findings suggestive of the beginnings of COVID-pneumonia with subtle ground glass opacity in the lateral mid and lower right lung. Vital signs normal but patient was initially hypoxic and put on oxygen. He improved and was no longer hypoxic, so oxygen removed. Patient denied shortness of breath or chest pain. He developed nausea, vomiting, diarrhea overnight on admission which was likely due to COVID. Patient continued to receive hospital care from 11/8/2022-11/10/2022 including IV fluids, vitamin C and zinc; no steroids needed. Monoclonal antibody treatment was considered as outpatient after discharge on 11/10/2022, as patient was eligible through 11/11/2022. Unknown if patient received MAB treatment.  On 11/22/2022, the patient presented at the emergency room with persistent cough and fevers. He was tested for COVID-19 and had positive COVID-19 antigen and PCR test results on 11/22/2022. He initially had tested positive on 11/6/2022. Patient complained of weakness, congestion, diarrhea, had a coarse deep sounding cough, and was dehydrated ? IV fluids given. Chest x-ray on 11/22/2022 showed no evidence of pneumonia; significantly low lung volumes; No definite focal airspace disease; mild central vascular congestion. Patient was admitted to the hospital on 11/22/2022 with principal problem of COVID-19 Virus Infection and secondary problem of Urinary Tract Infection associated with indwelling catheter. Further treatment and discharge information unknown.   On 11/30/2022, patient presented to the emergency room with 24-hour history of shortness of breath, cough, fever, fatigue and diarrhea. He had respiratory distress and hypoxia requiring oxygen. He was tested on 12/1/2022 for COVID-19 and had a positive NAA test. He initially tested COVID-19 positive on 11/6/2022, tested positive again on 11/22/2022, and on 12/1/2022. Patient was admitted to the hospital on 11/30/2022. Treatment included oxygen, steroids, nebulizers, broad spectrum antibiotics, and spot doses of diuretic. His condition worsened and on 12/4/2022 he requested to be transitioned to comfort measures. Patient expired on 12/5/2022. Death abstract states:  Acute Respiratory Failure, Pneumonia, and COVID-19 as causes of death.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Diuretic therapy, Dyspnoea, Exposure to SARS-CoV-2, Fatigue, General physical health deterioration
Clinical narrative: Patient had symptom onset on 11/6/2022 with cough and body aches. He tested positive for COVID-19 on 11/6/2022 at store with a NAA test. He had a known exposure to a positive COVID-19 case. Patient?s oncologist ordered outpatient monoclonal antibody infusion to treat the COVID. After IV insertion on 11/7/2022 in the outpatient department, patient had syncope and collapse and therefore he never received the monoclonal antibody infusion. He was admitted directly to the hospital for principal problem of syncope and collapse. and secondarily for COVID-19. Chest x-ray on 11/7/2022 showed findings suggestive of the beginnings of COVID-pneumonia with subtle ground glass opacity in the lateral mid and lower right lung. Vital signs normal but patient was initially hypoxic and put on oxygen. He improved and was no longer hypoxic, so oxygen removed. Patient denied shortness of breath or chest pain. He developed nausea, vomiting, diarrhea overnight on admission which was likely due to COVID. Patient continued to receive hospital care from 11/8/2022-11/10/2022 including IV fluids, vitamin C and zinc; no steroids needed. Monoclonal antibody treatment was considered as outpatient after discharge on 11/10/2022, as patient was eligible through 11/11/2022. Unknown if patient received MAB treatment.  On 11/22/2022, the patient presented at the emergency room with persistent cough and fevers. He was tested for COVID-19 and had positive COVID-19 antigen and PCR test results on 11/22/2022. He initially had tested positive on 11/6/2022. Patient complained of weakness, congestion, diarrhea, had a coarse deep sounding cough, and was dehydrated ? IV fluids given. Chest x-ray on 11/22/2022 showed no evidence of pneumonia; significantly low lung volumes; No definite focal airspace disease; mild central vascular congestion. Patient was admitted to the hospital on 11/22/2022 with principal problem of COVID-19 Virus Infection and secondary problem of Urinary Tract Infection associated with indwelling catheter. Further treatment and discharge information unknown.   On 11/30/2022, patient presented to the emergency room with 24-hour history of shortness of breath, cough, fever, fatigue and diarrhea. He had respiratory distress and hypoxia requiring oxygen. He was tested on 12/1/2022 for COVID-19 and had a positive NAA test. He initially tested COVID-19 positive on 11/6/2022, tested positive again on 11/22/2022, and on 12/1/2022. Patient was admitted to the hospital on 11/30/2022. Treatment included oxygen, steroids, nebulizers, broad spectrum antibiotics, and spot doses of diuretic. His condition worsened and on 12/4/2022 he requested to be transitioned to comfort measures. Patient expired on 12/5/2022. Death abstract states:  Acute Respiratory Failure, Pneumonia, and COVID-19 as causes of death.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Lung opacity, Nausea, Pain, Pulmonary congestion
Clinical narrative: Patient had symptom onset on 11/6/2022 with cough and body aches. He tested positive for COVID-19 on 11/6/2022 at store with a NAA test. He had a known exposure to a positive COVID-19 case. Patient?s oncologist ordered outpatient monoclonal antibody infusion to treat the COVID. After IV insertion on 11/7/2022 in the outpatient department, patient had syncope and collapse and therefore he never received the monoclonal antibody infusion. He was admitted directly to the hospital for principal problem of syncope and collapse. and secondarily for COVID-19. Chest x-ray on 11/7/2022 showed findings suggestive of the beginnings of COVID-pneumonia with subtle ground glass opacity in the lateral mid and lower right lung. Vital signs normal but patient was initially hypoxic and put on oxygen. He improved and was no longer hypoxic, so oxygen removed. Patient denied shortness of breath or chest pain. He developed nausea, vomiting, diarrhea overnight on admission which was likely due to COVID. Patient continued to receive hospital care from 11/8/2022-11/10/2022 including IV fluids, vitamin C and zinc; no steroids needed. Monoclonal antibody treatment was considered as outpatient after discharge on 11/10/2022, as patient was eligible through 11/11/2022. Unknown if patient received MAB treatment.  On 11/22/2022, the patient presented at the emergency room with persistent cough and fevers. He was tested for COVID-19 and had positive COVID-19 antigen and PCR test results on 11/22/2022. He initially had tested positive on 11/6/2022. Patient complained of weakness, congestion, diarrhea, had a coarse deep sounding cough, and was dehydrated ? IV fluids given. Chest x-ray on 11/22/2022 showed no evidence of pneumonia; significantly low lung volumes; No definite focal airspace disease; mild central vascular congestion. Patient was admitted to the hospital on 11/22/2022 with principal problem of COVID-19 Virus Infection and secondary problem of Urinary Tract Infection associated with indwelling catheter. Further treatment and discharge information unknown.   On 11/30/2022, patient presented to the emergency room with 24-hour history of shortness of breath, cough, fever, fatigue and diarrhea. He had respiratory distress and hypoxia requiring oxygen. He was tested on 12/1/2022 for COVID-19 and had a positive NAA test. He initially tested COVID-19 positive on 11/6/2022, tested positive again on 11/22/2022, and on 12/1/2022. Patient was admitted to the hospital on 11/30/2022. Treatment included oxygen, steroids, nebulizers, broad spectrum antibiotics, and spot doses of diuretic. His condition worsened and on 12/4/2022 he requested to be transitioned to comfort measures. Patient expired on 12/5/2022. Death abstract states:  Acute Respiratory Failure, Pneumonia, and COVID-19 as causes of death.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory distress, Respiratory tract congestion, SARS-CoV-2 test positive, Syncope
Clinical narrative: Patient had symptom onset on 11/6/2022 with cough and body aches. He tested positive for COVID-19 on 11/6/2022 at store with a NAA test. He had a known exposure to a positive COVID-19 case. Patient?s oncologist ordered outpatient monoclonal antibody infusion to treat the COVID. After IV insertion on 11/7/2022 in the outpatient department, patient had syncope and collapse and therefore he never received the monoclonal antibody infusion. He was admitted directly to the hospital for principal problem of syncope and collapse. and secondarily for COVID-19. Chest x-ray on 11/7/2022 showed findings suggestive of the beginnings of COVID-pneumonia with subtle ground glass opacity in the lateral mid and lower right lung. Vital signs normal but patient was initially hypoxic and put on oxygen. He improved and was no longer hypoxic, so oxygen removed. Patient denied shortness of breath or chest pain. He developed nausea, vomiting, diarrhea overnight on admission which was likely due to COVID. Patient continued to receive hospital care from 11/8/2022-11/10/2022 including IV fluids, vitamin C and zinc; no steroids needed. Monoclonal antibody treatment was considered as outpatient after discharge on 11/10/2022, as patient was eligible through 11/11/2022. Unknown if patient received MAB treatment.  On 11/22/2022, the patient presented at the emergency room with persistent cough and fevers. He was tested for COVID-19 and had positive COVID-19 antigen and PCR test results on 11/22/2022. He initially had tested positive on 11/6/2022. Patient complained of weakness, congestion, diarrhea, had a coarse deep sounding cough, and was dehydrated ? IV fluids given. Chest x-ray on 11/22/2022 showed no evidence of pneumonia; significantly low lung volumes; No definite focal airspace disease; mild central vascular congestion. Patient was admitted to the hospital on 11/22/2022 with principal problem of COVID-19 Virus Infection and secondary problem of Urinary Tract Infection associated with indwelling catheter. Further treatment and discharge information unknown.   On 11/30/2022, patient presented to the emergency room with 24-hour history of shortness of breath, cough, fever, fatigue and diarrhea. He had respiratory distress and hypoxia requiring oxygen. He was tested on 12/1/2022 for COVID-19 and had a positive NAA test. He initially tested COVID-19 positive on 11/6/2022, tested positive again on 11/22/2022, and on 12/1/2022. Patient was admitted to the hospital on 11/30/2022. Treatment included oxygen, steroids, nebulizers, broad spectrum antibiotics, and spot doses of diuretic. His condition worsened and on 12/4/2022 he requested to be transitioned to comfort measures. Patient expired on 12/5/2022. Death abstract states:  Acute Respiratory Failure, Pneumonia, and COVID-19 as causes of death.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection, Vomiting
Clinical narrative: Patient had symptom onset on 11/6/2022 with cough and body aches. He tested positive for COVID-19 on 11/6/2022 at store with a NAA test. He had a known exposure to a positive COVID-19 case. Patient?s oncologist ordered outpatient monoclonal antibody infusion to treat the COVID. After IV insertion on 11/7/2022 in the outpatient department, patient had syncope and collapse and therefore he never received the monoclonal antibody infusion. He was admitted directly to the hospital for principal problem of syncope and collapse. and secondarily for COVID-19. Chest x-ray on 11/7/2022 showed findings suggestive of the beginnings of COVID-pneumonia with subtle ground glass opacity in the lateral mid and lower right lung. Vital signs normal but patient was initially hypoxic and put on oxygen. He improved and was no longer hypoxic, so oxygen removed. Patient denied shortness of breath or chest pain. He developed nausea, vomiting, diarrhea overnight on admission which was likely due to COVID. Patient continued to receive hospital care from 11/8/2022-11/10/2022 including IV fluids, vitamin C and zinc; no steroids needed. Monoclonal antibody treatment was considered as outpatient after discharge on 11/10/2022, as patient was eligible through 11/11/2022. Unknown if patient received MAB treatment.  On 11/22/2022, the patient presented at the emergency room with persistent cough and fevers. He was tested for COVID-19 and had positive COVID-19 antigen and PCR test results on 11/22/2022. He initially had tested positive on 11/6/2022. Patient complained of weakness, congestion, diarrhea, had a coarse deep sounding cough, and was dehydrated ? IV fluids given. Chest x-ray on 11/22/2022 showed no evidence of pneumonia; significantly low lung volumes; No definite focal airspace disease; mild central vascular congestion. Patient was admitted to the hospital on 11/22/2022 with principal problem of COVID-19 Virus Infection and secondary problem of Urinary Tract Infection associated with indwelling catheter. Further treatment and discharge information unknown.   On 11/30/2022, patient presented to the emergency room with 24-hour history of shortness of breath, cough, fever, fatigue and diarrhea. He had respiratory distress and hypoxia requiring oxygen. He was tested on 12/1/2022 for COVID-19 and had a positive NAA test. He initially tested COVID-19 positive on 11/6/2022, tested positive again on 11/22/2022, and on 12/1/2022. Patient was admitted to the hospital on 11/30/2022. Treatment included oxygen, steroids, nebulizers, broad spectrum antibiotics, and spot doses of diuretic. His condition worsened and on 12/4/2022 he requested to be transitioned to comfort measures. Patient expired on 12/5/2022. Death abstract states:  Acute Respiratory Failure, Pneumonia, and COVID-19 as causes of death.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Diverticulum
Clinical narrative: I did not have an adverse reaction to the vaccine. I have a pre-existing condition called diverticulosis that was diagnosed with a colonoscopy in 2019. I normally did not have complications or pain, but I had a flare up after the vaccine and saw my doctor. My doctor recommended a change in my diet to avoid having a flare up.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: na
Age: 8.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was scheduled to receive the second dose of Pfizer 5-11 years monovalent vaccine.  Pfizer 5-11 years Bivalent Booster vaccine dose was  incorrectly administered for the second dose in the primary series.  Patient observed for 15 minutes post vaccine administration and no adverse reaction noted upon departure.
Age: 94.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was scheduled to receive the second dose of Pfizer 5-11 years monovalent vaccine.  Pfizer 5-11 years Bivalent Booster vaccine dose was  incorrectly administered for the second dose in the primary series.  Patient observed for 15 minutes post vaccine administration and no adverse reaction noted upon departure.
Age: 1.92
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient was given monovalent Pfizer 6mo-<5yr for the 3rd dose instead of Pfizer bivalent 6mo-<5yr.  No treatment needed parent informed of given monovalent as the 3rd dose instead of bivalent to child
Age: 17.0
Sex: M
Vaccine: IPV
Symptoms: Abdominal pain upper, Asthenia, Headache, Nausea, Pain
Clinical narrative: Sx for 4 days:  Fever (T39.5 ) Nausea Body pain  headache  weakness  Stomache
Age: 17.0
Sex: M
Vaccine: IPV
Symptoms: Pyrexia
Clinical narrative: Sx for 4 days:  Fever (T39.5 ) Nausea Body pain  headache  weakness  Stomache
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The dose was administered after the BUD date. Moderna did a lot test and showed that the dose received was safe and effective.
Age: 6.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was scheduled to receive the second dose of Pfizer 5-11 years monovalent vaccine.  Pfizer 5-11 years Bivalent Booster vaccine dose was  incorrectly administered for the second dose in the primary series.  Patient observed for 15 minutes post vaccine administration and no adverse reaction noted upon departure.
Age: 50.0
Sex: F
Vaccine: UNK, VARZOS
Symptoms: Condition aggravated, Hypoaesthesia, Neuropathy peripheral, Urticaria
Clinical narrative: Hives upon vaccination that lasted for 2 weeks (daily occurance- now resolved) Significant increase in peripheral neuropathy and numbness since vaccination- not resolved
Age: 50.0
Sex: F
Vaccine: UNK, VARZOS
Symptoms: Neurological symptom, Urticaria
Clinical narrative: Hives upon vaccination that lasted for 2 weeks (daily occurance- now resolved) Significant increase in peripheral neuropathy and numbness since vaccination- not resolved
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Coagulation test, Ischaemic cerebral infarction, Magnetic resonance imaging
Clinical narrative: Left Lateral Ischemic Medullary Infarct
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: na
Age: 40.0
Sex: M
Vaccine: MENB
Symptoms: Extra dose administered
Clinical narrative: Patient received 2nd dose of 2 dose series of Bexsero on 1/30/23. Error in rx processing at pharmacy caused omission of vaccine report to agency. Patient received an additional dose of Bexsero at MD office at appt on 2/24/23.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Adenocarcinoma metastatic, Adenocarcinoma of the cervix, Biopsy, Central venous catheterisation, Cervix cancer metastatic
Clinical narrative: METASTATIC ADENOCARCENOUS OF THE CERVIX, METASTISIZED TO LIVER, LYMPH NODES, FATTY TISSUE IN STOMACH, AND OUTER SKIN OF VAGINA, THYROID ISSUES, GALLBLADDER PROBLEMS, BRITTLE TEETH
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Chemotherapy, Condition aggravated, Gallbladder disorder, Metastases to liver, Metastases to lymph nodes
Clinical narrative: METASTATIC ADENOCARCENOUS OF THE CERVIX, METASTISIZED TO LIVER, LYMPH NODES, FATTY TISSUE IN STOMACH, AND OUTER SKIN OF VAGINA, THYROID ISSUES, GALLBLADDER PROBLEMS, BRITTLE TEETH
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Metastases to skin, Metastases to stomach, Metastases to vagina, Pulmonary thrombosis, Radiotherapy
Clinical narrative: METASTATIC ADENOCARCENOUS OF THE CERVIX, METASTISIZED TO LIVER, LYMPH NODES, FATTY TISSUE IN STOMACH, AND OUTER SKIN OF VAGINA, THYROID ISSUES, GALLBLADDER PROBLEMS, BRITTLE TEETH
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Sepsis, Smear cervix, Surgery, Teeth brittle, Thyroid disorder
Clinical narrative: METASTATIC ADENOCARCENOUS OF THE CERVIX, METASTISIZED TO LIVER, LYMPH NODES, FATTY TISSUE IN STOMACH, AND OUTER SKIN OF VAGINA, THYROID ISSUES, GALLBLADDER PROBLEMS, BRITTLE TEETH
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient was given monovalent Pfizer 6mo-<5yr for the 3rd dose instead of Pfizer bivalent 6mo-<5yr.  No treatment needed Parents were notified that monovalent dose was given instead of bivalent
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Gait disturbance, Injected limb mobility decreased, Loss of personal independence in daily activities, Malaise, Mobility decreased
Clinical narrative: She got her vaccine, and her arm was sore for a couple of days and continued to be sore.  It got worse and worse, muscles got weak and could not do things with her arm.  She started having problems with her legs, and stopped, they were stiff.  She now has front and back stiffness of her legs, it takes her a while to start walking.  The arm is hurting when she's reaching, trying to cover with a blanket.  It's a mobility situation, but does have pain when she tries to reach and try to cover herself and not able to do that.  The legs are a mobility issue not pain.   She saw her doctor for her symptoms, who wanted her to get an x-ray as that time she did not have the right arm involved, but only the left  The day she went into her her legs did not hurt her.  Her arm was x-rayed all the way up to the shoulder, no arthritis, the bones looked okay, the AC joint had some space, but nothing too concerning.  She wrote her and told her that she was not doing well, and she has an appointment for FU this week.  She cannot pick anything up off the floor due to the stiffness in her legs.  She is very active, she is in a pool 3 days a week for an hour with water aerobics, she is also doing dance, and does something every single day.  She was possibly going to be sent for PT, but due to her activity she did not know if she needed it, and says what's the sense of it as she is going these other things.  This affects both arms, back and front of legs, cannot walk and has to wait to walk after she sits.  She forces herself to get going, and night is terrible.  Trying to turn in the bed and covering herself is severe.  She cannot do her arm movements much a far as dancing.  She has a stretch out flap and stretches herself real good to be able to dance.   Getting dressed is very difficult.    She went online and found us and found Guillian barre syndrome, and has not gone into her yet with these.    She went this past week to have a message thinking it would help her, which did not help her.  She does take Tylenol from time to time and helps with mobility.  She is not in pain, but has slowed her down considerably.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscular weakness, Musculoskeletal stiffness, Pain, Pain in extremity, X-ray limb normal
Clinical narrative: She got her vaccine, and her arm was sore for a couple of days and continued to be sore.  It got worse and worse, muscles got weak and could not do things with her arm.  She started having problems with her legs, and stopped, they were stiff.  She now has front and back stiffness of her legs, it takes her a while to start walking.  The arm is hurting when she's reaching, trying to cover with a blanket.  It's a mobility situation, but does have pain when she tries to reach and try to cover herself and not able to do that.  The legs are a mobility issue not pain.   She saw her doctor for her symptoms, who wanted her to get an x-ray as that time she did not have the right arm involved, but only the left  The day she went into her her legs did not hurt her.  Her arm was x-rayed all the way up to the shoulder, no arthritis, the bones looked okay, the AC joint had some space, but nothing too concerning.  She wrote her and told her that she was not doing well, and she has an appointment for FU this week.  She cannot pick anything up off the floor due to the stiffness in her legs.  She is very active, she is in a pool 3 days a week for an hour with water aerobics, she is also doing dance, and does something every single day.  She was possibly going to be sent for PT, but due to her activity she did not know if she needed it, and says what's the sense of it as she is going these other things.  This affects both arms, back and front of legs, cannot walk and has to wait to walk after she sits.  She forces herself to get going, and night is terrible.  Trying to turn in the bed and covering herself is severe.  She cannot do her arm movements much a far as dancing.  She has a stretch out flap and stretches herself real good to be able to dance.   Getting dressed is very difficult.    She went online and found us and found Guillian barre syndrome, and has not gone into her yet with these.    She went this past week to have a message thinking it would help her, which did not help her.  She does take Tylenol from time to time and helps with mobility.  She is not in pain, but has slowed her down considerably.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Arthralgia, Herpes simplex test negative, Peripheral swelling, Rash, Rash erythematous
Clinical narrative: Reaction with features of a serum sickness-like reaction. Acute onset painful and itchy erythematous rash- papulovesicular, face and neck swelling, hand swelling . Later with joint pain- knees especially and urticaria. No respiratory symptoms. No fever
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash papular, Rash pruritic, Serum sickness, Swelling, Swelling face
Clinical narrative: Reaction with features of a serum sickness-like reaction. Acute onset painful and itchy erythematous rash- papulovesicular, face and neck swelling, hand swelling . Later with joint pain- knees especially and urticaria. No respiratory symptoms. No fever
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Urticaria, Varicella virus test negative
Clinical narrative: Reaction with features of a serum sickness-like reaction. Acute onset painful and itchy erythematous rash- papulovesicular, face and neck swelling, hand swelling . Later with joint pain- knees especially and urticaria. No respiratory symptoms. No fever
Age: 33.0
Sex: M
Vaccine: HEP, JEV1, MMR
Symptoms: Erythema, Malaise, Posture abnormal, Snoring
Clinical narrative: Patient notified staff of past passing out with blood draws.  Since patient was in the readiness lab he was placed in a reclined position for safety.  Blood was drawn with no issues.  patient was then sat up per his request.  Patient received Hep B and then JEV with no issues.  When his MMR was given with no issues.  Patient was then sitting there and then got up about 45 seconds after vaccines patient reported feeling not well.  Patient was assisted to set back in chair in a reclined position.  Patient's neck hyper-extended, face turned red, patient made a snoring sound.  Some thrashing and tense body posturing was noted.  After a sternal rub he appeared to be out for about 45 seconds.  Ice was applied.  Patient woke and spoke.  Appropriate, oriented and was able to observe all questions.  Patient was resting comfortably, drinking water and observed for about 1 hour.  Discharged home with no issues by Clinical Staff
Age: 1.33
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: patient was given monovalent Pfizer 6mo-<5yr for the 3rd dose instead of Pfizer bivalent 6mo-<5yr.  No treatment needed Parents notified that monovalent was given instead of bivalent
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Cognitive disorder, Computerised tomogram abdomen, Computerised tomogram head, Feeling abnormal, Gastrointestinal disorder
Clinical narrative: severe brain fog; peripheral neuropathy; gut issues; cognitive issues; blurry vision; vision issues other than blurred vision;
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Neuropathy peripheral, Ultrasound abdomen, Vision blurred, Visual impairment
Clinical narrative: severe brain fog; peripheral neuropathy; gut issues; cognitive issues; blurry vision; vision issues other than blurred vision;
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given dose 1 of Moderna series on 2/21/2023  from a vial which was placed in refrigeration on 2/1/2023, meaning it was stable until 3/3/2023 (30 days).  It was discovered after administration that the manufacturer expiration of the vial was 2/21/2023.  Moderna was contacted to assist in determining if vaccine was to be considered valid or if revaccination was needed.  Moderna completed an analysis and determined that "The vaccine administered on February 23, 2023  from lot number AS1420B maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. "   A physician reviewed the scenario  and Moderna analysis and determined that the dose was to be considered valid, and the series was to be completed per Moderna guidelines.  Family was alerted to this incident and was in agreement with plan, and did not note any symptoms, or adverse reactions.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient should have received the Pfizer Monovalent as her first Covid vaccine dose.  She was given the Bivalent.
Age: 36.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, Product use issue
Clinical narrative: Vaccine had been in the fridge >30 days and was considered expired based on the BUD of 02/10/23
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient recieved a thier 2nd dose of Pfizer and Jynneos at the same time.  Shortly after, they tested Positive for COVID and recieved Paxlovid.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was received expired covid 6mo-4yr monovalent vaccine. Vaccine was drawn up on 2/28/23 at 1440. Vaccine was administered to patient on 3/1/23 at 1544.
Age: 7.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: I looked at our Pfizer inventory today to check for possible incorrect expiration dates (because of the 10 week fridge time after receiving shipment). I found two incorrect expiration dates. I ran a "dosage report" in Immunization Information System to see if any patients were vaccinated with these two expired vaccines, there are two patients.  COVID PFR BIV 5y-11y GK1657 - expired 12/27/2022 (report ran from 12/29/2022 - 03/02/2022 given the two additional days per Pfizer, see attached)
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 11.0
Sex: M
Vaccine: MENB
Symptoms: Expired product administered
Clinical narrative: medical assistant gave an expired Trumenba given on 3/2/2023 it expired on 2/28/23
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: I looked at our Pfizer inventory today to check for possible incorrect expiration dates (because of the 10 week fridge time after receiving shipment). I found two incorrect expiration dates. I ran a "dosage report" in database to see if any patients were vaccinated with these two expired vaccines. COVID PFR MONO 6m-4y FT9142 - expired 11/16/2022  (report ran from 11/18/2022 - 03/02/2022 given the two additional days per Pfizer, see attached)
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Local reaction, Peripheral swelling
Clinical narrative: Large local reaction on leg with erythema and swelling
Age: 7.0
Sex: F
Vaccine: DTAP, TDAP
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: Patient inadvertently received DTaP even though she was due for Tdap.  She was subsequently administered Tdap immediately after.  No adverse reactions in clinic.  Error was discovered after patient left office.
Age: 0.75
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: patient was given monovalent Pfizer 6mo-<5yr for the 3rd dose instead of Pfizer bivalent 6mo-<5yr.  No treament needed no reaction parents notified of monovalent given instead of bivalent
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The patient is age 8 years of age and a Moderna 12 years and older vaccine was administered. The parent was advised, the patient waited in the clinic for 20 minutes, confirming that he felt ok prior to leaving.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Angiogram cerebral, Cerebrovascular accident, Echocardiogram, Headache
Clinical narrative: In January 2022 my  husband noticed problems with my speech, went to doctor and after scans they found I had 3 CVA events. Currently taking medication Crestor, speech therapy, physical therapy, and continuing to work through headaches.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Scan brain, Speech disorder
Clinical narrative: In January 2022 my  husband noticed problems with my speech, went to doctor and after scans they found I had 3 CVA events. Currently taking medication Crestor, speech therapy, physical therapy, and continuing to work through headaches.
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Gait disturbance, Headache, Myalgia
Clinical narrative: Tiredness; muscle pain in legs; headache; extreme shivering; mild fever; unable to walk without assistance.
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Tiredness; muscle pain in legs; headache; extreme shivering; mild fever; unable to walk without assistance.
Age: 0.58
Sex: F
Vaccine: DTAPHEPBIP, PNC13
Symptoms: Administration site erythema, Erythema
Clinical narrative: erythema few minutes after administration at site and on neck
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Haematuria
Clinical narrative: Gross hematuria. Started 4 hours after injection. Cleared about 12 hours later.
Age: 72.0
Sex: M
Vaccine: COVID19-2, FLUR4
Symptoms: Expired product administered
Clinical narrative: Expired Moderna Bivalent vaccine given on 2/28/2023.   This vaccine was drawn up on 2/20/2023 and was to be given by 2/21/2023.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Musculoskeletal disorder
Clinical narrative: Pt woke up the morning after vaccine and could not use his legs. This lasted approximately. 2 hours then he regained movement.